Why Thermo Fisher Scientific’s ASMS 2026 launch matters for drug discovery workflows
Thermo Fisher Scientific unveils new Orbitrap platforms at ASMS 2026. Find out how they could reshape drug discovery workflows today!
Why the Radoff-JEC bid for Seer is bigger than a small-cap biotech takeover fight
Find out why Seer’s activist battle could reshape investor thinking on proteomics, diagnostics platforms and biotech value creation.
Why Thermo Fisher’s new Gothenburg lab matters for the next phase of complex drug development
Complex therapies need deeper trial data. Thermo Fisher’s Gothenburg lab shows why bioanalysis is becoming a CRO battleground.
What SCIEX’s Echo MS+ compatibility with ZenoTOF 8600 signals for modern drug discovery labs
SCIEX integrates Echo MS+ with ZenoTOF 8600 to reshape high-throughput mass spectrometry workflows. Find out why this matters for discovery labs.
Can Enodia’s SEC61-targeting platform redefine druggability in secreted and membrane proteins?
Enodia Therapeutics raised €20.7M to advance AI-powered small molecules targeting SEC61 for selective protein degradation. Find out what this could change.
Illumina expands AI-powered multiomic strategy with launch of Connected Multiomics software platform
Illumina, Inc. has officially launched Connected Multiomics, a cloud-native software platform designed to unify and analyze complex biological data across multiple omic modalities including genomics, transcriptomics, proteomics, and spatial biology. The tool is now widely available after a year-long early access program involving over 40 research groups. Positioned as a user-friendly yet technically powerful analysis […]